**Core Concept**
The question pertains to the genetic predisposition of breast cancer, specifically the identification of genes associated with autosomal dominant inheritance. Autosomal dominant inheritance implies that a mutation in one allele of a gene is sufficient to cause the condition. In the context of breast cancer, this means that individuals with a mutated gene have an increased risk of developing the disease.

**Why the Correct Answer is Right**
BRCA1 and BRCA2 are tumor suppressor genes that play crucial roles in maintaining genomic stability. Mutations in these genes can lead to an increased risk of breast and ovarian cancer. The proteins encoded by BRCA1 and BRCA2 are involved in DNA repair mechanisms, specifically homologous recombination. When these genes are mutated, DNA damage is not efficiently repaired, leading to genetic instability and an increased risk of cancer. The inheritance pattern of BRCA1 and BRCA2 mutations is autosomal dominant, meaning that a single copy of the mutated gene is sufficient to increase the risk of breast cancer.

**Why Each Wrong Option is Incorrect**
**Option A:** PTEN and KAI are genes involved in different pathways. PTEN is a tumor suppressor gene that regulates the PI3K/AKT signaling pathway, whereas KAI is not a recognized gene associated with breast cancer.

**Option C:** APC is a tumor suppressor gene associated with familial adenomatous polyposis (FAP), a condition characterized by the development of hundreds to thousands of polyps in the colon. While APC mutations can increase the risk of colorectal cancer, they are not associated with an increased risk of breast cancer.

**Option D:** P53 is a tumor suppressor gene that plays a critical role in regulating the cell cycle and preventing cancer. Mutations in P53 are associated with Li-Fraumeni syndrome, a condition that increases the risk of multiple types of cancer, including breast cancer. However, P53 mutations are not typically associated with an autosomal dominant inheritance pattern of breast cancer.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that BRCA1 and BRCA2 mutations are associated with an increased risk of breast and ovarian cancer, and individuals with a family history of these cancers should undergo genetic counseling and testing.

**✓ Correct Answer: B. BRCA 1 and 2**